Clinical trials
Phase 3 Anemia, Refractory, with Excess of Blasts trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2002 | 2 |
| 2004 | 1 |
| 2005 | 2 |
| 2007 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2018 | 1 |
| 2019 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Unknown status | 3 |
| Terminated | 2 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| European Organisation for Research and Treatment of Cancer - EORTC | 3 |
| Traws Pharma, Inc. | 3 |
| National Cancer Institute (NCI) | 2 |
| Celgene | 1 |
| Children's Oncology Group | 1 |
| Dartmouth-Hitchcock Medical Center | 1 |
| Eastern Cooperative Oncology Group | 1 |
| Leukemia Research Fund | 1 |
| Medical College of Wisconsin | 1 |
| Medical Research Council | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anemia, Refractory, with Excess of Blasts | 24 |
| Myelodysplastic Syndromes | 18 |
| Leukemia | 11 |
| Leukemia, Myelomonocytic, Chronic | 11 |
| Leukemia, Myeloid, Acute | 7 |
| Anemia, Refractory | 6 |
| Myeloproliferative Disorders | 5 |
| Congenital Abnormalities | 4 |
| Leukemia, Erythroblastic, Acute | 4 |
| Leukemia, Megakaryoblastic, Acute | 4 |
Trials
Showing 76 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.